Skip to content

Operating Income at other companies

Stryker logo
StrykerSYK
$936M+11.8%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$22.58M+49.0%
Enovis logo
EnovisENOV
$6.53M+114%
OrthoPediatrics logo
OrthoPediatricsKIDS
-$8.34M+24.1%
Medtronic logo
MedtronicMDT
$1.87B+30.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$196.7M+1.6%
Gross profit$139.5M+14.7%
Net income-$20.9M+60.6%
EPS (diluted)-$0.52+61.5%

Balance sheet

See full
Cash & equivalents$120.3M+108%
Total debt$237.5M+32.3%
Total equity$435.2M-5.0%
Total assets$886.6M+7.7%

Cash flow

See full
Operating cash flow-$17.6M+4.2%
CapEx$10.7M+58.3%
Free cash flow-$28.3M-12.5%

Valuation

See full
Market cap$376.33M-7.1%
Enterprise value$493.54M-6.3%
P/S0.5×0.0×

Profitability

See full
Gross margin70.7%+3.6pp
Operating margin-5.8%-2.1pp
Net margin-7.3%-2.7pp
FCF margin-9.3%-1.7pp

Returns & leverage

See full
Return on equity-13.4%-4.6pp
Debt / equity0.5×+0.2×
Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Orthofix Medical Inc.'s operating income?
Orthofix Medical Inc. (OFIX) reported operating income of -$14.44M in Q1 2026.
How has Orthofix Medical Inc.'s operating income changed year-over-year?
Orthofix Medical Inc.'s operating income increased by 70.5% year-over-year, from -$48.87M to -$14.44M.
What is the long-term trend for Orthofix Medical Inc.'s operating income?
Over 4 years (2021 to 2025), Orthofix Medical Inc.'s operating income has grown at a 77.2% compound annual growth rate (CAGR), from -$8.32M to -$81.92M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.